Renaissance Group LLC cut its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 0.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,907 shares of the company’s stock after selling 438 shares during the quarter. Renaissance […]
Principal Financial Group Inc. trimmed its holdings in shares of Chemed Co. (NYSE:CHE – Free Report) by 0.6% during the 4th quarter, Holdings Channel reports. The fund owned 55,705 shares of the company’s stock after selling 347 shares during the period. Principal Financial Group Inc.’s holdings in Chemed were worth $32,574,000 as of its most […]
Chemed (NYSE:CHE – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $6.60 EPS for the quarter, topping analysts’ consensus estimates of $6.25 by $0.35, Briefing.com reports. Chemed had a net margin of 12.03% and a return on equity of 33.63%. The business had revenue of $585.90 million during the quarter, […]
Chemed (NYSE:CHE – Get Free Report) had its price target raised by analysts at Oppenheimer from $625.00 to $650.00 in a report released on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 3.11% from the company’s current price. Chemed Stock Performance Shares […]
Chemed (NYSE:CHE – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $23.30-$23.70 for the period, compared to the consensus estimate of $23.01. Chemed also updated its FY 2024 guidance to 23.300-23.700 EPS. Wall Street Analyst Weigh In Several analysts recently issued reports on the […]